Zogenix Inc Asset Turnover Ratio (ZGNX), as of fourth quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Zogenix Inc   (NASDAQ: ZGNX)
 

Zogenix Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Zogenix Inc asset turnover ratio, the ability of Zogenix Inc 's assets to generate revenue in the fourth quarter 2021, increased sequentially to 0.16 in the fourth quarter (Dec 31 2021), yet the ratio remained below the average, as ZGNX's position remain challenging.

Within sector 182 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2021 compared to the preceding quarter from 3416 to 3771.

Asset Turnover Ratio Definition



ZGNX Asset Turnover Ratio (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Asset Change -53.92 % -28.21 % -2.44 % -5.27 % 146.41 %
Y / Y Revenue Change 212.95 % 690.56 % 1720.64 % 1157.72 % 336.22 %
Asset Turnover Ratio (TTM) 0.16 0.1 0.06 0.04 0.02
ZGNX's Total Ranking # 3771 # 3416 # 3643 # 3817 # 4653
Seq. Asset Change -5.74 % -8.09 % -6.91 % -42.87 % 46.86 %
Seq. Revenue Change 17.68 % 20.34 % 37.31 % 60.95 % 197.27 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 183
Healthcare Sector # 528
Overall Market # 3771

Asset Turnover Ratio Statistics
High Average Low
0.56 0.19 0.01
(Dec 31 2012)   (Sep 30 2018)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Assets at quarter ending Dec 31 2021
Novocure Limited  0.48 $ 535.031  Millions$ 1,106.159  Millions
Alphatec Holdings Inc   0.48 $ 243.212  Millions$ 503.923  Millions
Enovis Corp  0.48 $ 3,854.303  Millions$ 8,028.441  Millions
Pacific Health Care Organization Inc  0.48 $ 5.403  Millions$ 11.273  Millions
China Pharma Holdings Inc  0.48 $ 9.642  Millions$ 20.156  Millions
Smith and Nephew Plc  0.48 $ 5,221.000  Millions$ 10,920.000  Millions
Neurometrix Inc   0.47 $ 8.253  Millions$ 17.418  Millions
Redhill Biopharma Ltd   0.47 $ 85.757  Millions$ 181.188  Millions
Vivos Therapeutics Inc   0.47 $ 16.885  Millions$ 35.706  Millions
Maravai Lifesciences Holdings Inc   0.47 $ 799.240  Millions$ 1,691.494  Millions
Pfizer Inc  0.47 $ 81,288.000  Millions$ 172,350.500  Millions
Vanda Pharmaceuticals Inc   0.47 $ 268.682  Millions$ 571.099  Millions
Imac Holdings Inc   0.47 $ 14.386  Millions$ 30.638  Millions
Catalent Inc   0.47 $ 4,483.500  Millions$ 9,566.775  Millions
Cytosorbents Corporation  0.47 $ 43.166  Millions$ 92.565  Millions
Bio techne Corp  0.46 $ 1,029.575  Millions$ 2,220.186  Millions
Steris Plc  0.46 $ 4,247.909  Millions$ 9,250.599  Millions
Evolus Inc   0.46 $ 99.673  Millions$ 217.441  Millions
Coherus Oncology inc   0.46 $ 326.551  Millions$ 713.476  Millions
Biogen Inc   0.46 $ 10,981.700  Millions$ 24,002.275  Millions
Avanos Medical Inc   0.46 $ 744.600  Millions$ 1,631.150  Millions
Biohaven Ltd   0.46 $ 462.509  Millions$ 1,014.365  Millions
Dentsply Sirona Inc   0.46 $ 4,222.000  Millions$ 9,260.750  Millions
Intuitive Surgical Inc   0.45 $ 5,710.100  Millions$ 12,581.750  Millions
Syndax Pharmaceuticals Inc   0.45 $ 139.709  Millions$ 307.973  Millions
Standard Biotools Inc   0.45 $ 130.581  Millions$ 287.979  Millions
Sol gel Technologies Ltd   0.45 $ 31.272  Millions$ 69.189  Millions
Livanova Plc  0.45 $ 1,035.365  Millions$ 2,292.513  Millions
Ati Physical Therapy Inc   0.45 $ 627.871  Millions$ 1,390.778  Millions
Immucell Corporation  0.45 $ 19.243  Millions$ 43.012  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.